designed a novel dual-functional ligand that inhibits LDHA, with activity 9 times higher than sodium oxalate,however, subsequent reports on detailed molecular modeling studies and biological tests targeting cancer cell lines have not been forthcoming (111). The gene discussed is LDHA; the disease is cancer.